The Cost of Hope (27 page)
“Lessons of a $618,616 Death”
http://www.businessweek.com/magazine/content/10_11/b4170032321836.htm
“End-of-Life Warning at $618,616 Makes Me Wonder Was It Worth It”
http://www.bloomberg.com/apps/news?pid=newsarchive&sid=avRFGNF6Qw_w
In addition, I draw extensively on the work of three Bloomberg colleagues: Chuck Babcock, Ken Wells, and Shannon Pettypiece. I depended heavily on Chuck’s March 4, 2010, Bloomberg articles on interpreting the cost of medications (“Avastin Dose Costing $6,600 Became $27,360 in Hospital Billing,”
http://www.bloomberg.com/apps/news?pid=newsarchive&sid=aXuekMxp5Yh4
) and of scans (“Chest Scan Costs $550 to $3,232 in Opaque Market for Radiology,”
http://www.bloomberg.com/apps/news?pid=newsarchive&sid=auQxUuJ1.Srk
), as well as on Ken and Shannon’s article on the development of Sutent and other targeted therapies (“Miracle Cancer Drug Extends Life with $48,720 Cost,”
http://www.bloomberg.com/apps/news?pid=newsarchive&sid=aER.9zj2HmSk
). Ken’s detailed interviews with Dr. Keith Flaherty were also invaluable.
I gratefully acknowledge Bloomberg’s permission to use this material.
A
MANDA
B
ENNETT
is an executive editor at Bloomberg News, directing special projects and investigations, and was the co-chair of the Pulitzer Prize Board. She formerly served as editor of
The Philadelphia Inquirer
, editor of the
Herald-Leader
(Lexington, Kentucky), managing editor for
The Oregonian
(Portland, Oregon), and Atlanta bureau chief (among numerous other posts) at
The Wall Street Journal
. In 1997 Bennett shared the Pulitzer Prize for national reporting with her
Journal
colleagues, and in 2001 she led an
Oregonian
team to a Pulitzer for public service. She is the author of previous books including
In Memoriam
(1997),
The Man Who Stayed Behind
(1993), and
The Death of the Organization Man
(1990).
